📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Agonist efficacy at the ß2AR is driven by the faster association rate of the Gs protein. (2025)

First Author: Harwood CR

Attributed to: Role of pharmacological activity of autoantibodies in ME/CFS funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2025.1367991

PubMed Identifier: 40213684

Publication URI: http://europepmc.org/abstract/MED/40213684

Type: Journal Article/Review

Volume: 16

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812